Biotek-snakken — August 2021
-
Enlivex - stiger 27% i dag på nyheden om godkendelse af et fase 2b studie for op til 152 hårdt ramte COVID-patienter. https://enlivex.com/investor-relations/
-
3 Top Biotech Stocks to Buy in August
https://www.proinvestor.com/investornyt/692203/3-top-biotech-stocks-to-buy-in-august -
2 Beaten-Down Biotech Stocks: Are They
Bargains Now? https://www.proinvestor.com/investornyt/692217/2-beaten-down-biotech-stocks-are-they-bargains-now -
FDA finds fault with Axsome's depression filing, sinking stock
-
https://alligatorbioscience.se/en/alligator-bioscience-announces-immuno-oncology-research-collaboration-and-license-agreement-with-orion-corporation/ Alligator Bioscience indgår licens aftale med Orion
-
Deinove - må vente lidt længere på resultater fra fase 2 med DNV3837 mod c.diff. Det må være lige på trapperne selvom completion date desværre netop er skubbet 2 måneder på ClinicTrial.gov til nu oktober (og fortsat recruiting!?) -
https://clinicaltrials.gov/ct2/show/NCT03988855 Det er høj risiko (og tilmed fransk), men jeg synes altså det ligner en potentiel ret spændende historie indenfor antibiotic. https://www.deinove.com/en -
@Bioshare, måske ikke men 3.5 mdkk i potentielle milestone payments er da også til at tage med
Mig bekendt, kender man ikke de endelige detaljer på disse milestones, så hvornår og hvor svære de er at få melder historien intet om. Dog er det endnu et bevis på at Alligator's platform er attraktiv og med potentiale. Lidt positive nyheder, og så tilbage i skuffen med aktien 
-
Synes bestemt det er en fin nyhed. Betalingen up-front er formentlig symbolsk - og resterende bagtungt. Jamen lad os se hvad Orion tager i klinikken
Enig i at det sådanne aftaler der skal trække dem ud af kviksandet, og holder da mine aktier i selskabet. Håber nu mest at vi kommer til at se positive resultater af Mitazalimab (CD40)...så får vi en helt anden kurs end dagens. -
Sutro - FDA granted fast track designation for STRO-002
https://www.prnewswire.com/news-releases/sutro-biopharma-announces-stro-002-fda-fast-track-designation-for-patients-with-advanced-ovarian-cancer-301357368.html -
Cellectar - får $2 mill fra National Cancer Institute som donation til CLR 131 - https://www.cellectar.com/news-media/press-releases/detail/273/cellectar-awarded-2-0-million-phase-ii-nih-sbir-grant-to
-
3 Boring Healthcare Stocks Everyone Should Own https://www.proinvestor.com/investornyt/694764/3-boring-healthcare-stocks-everyone-should-own
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind